Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen Inc
(NQ:
OCGN
)
1.300
+0.070 (+5.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
32
33
Next >
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, DIDI and CRMD
August 03, 2021
NEW YORK, NY / ACCESSWIRE / August 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Product Safety
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
August 02, 2021
From
Kirby McInerney LLP
Via
Business Wire
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
August 02, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
Throw in The Towel, Ocugen Stock is Not Coming Back
August 02, 2021
The Delta variant may be extending the Covid-19 health crisis, but don't assume that means Covaxin can still change the game for OCGN stock
Via
InvestorPlace
Exposures
COVID-19
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, HMPT and DIDI
August 02, 2021
NEW YORK, NY / ACCESSWIRE / August 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Product Safety
CLASS ACTION UPDATE for SRAC, OCGN and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
August 01, 2021
NEW YORK, NY / ACCESSWIRE / August 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
LAWSUITS FILED AGAINST OCGN, HMPT and ATHA - Jakubowitz Law Pursues Shareholders Claims
July 30, 2021
NEW YORK, NY / ACCESSWIRE / July 30, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, OCGN and BLCT
July 30, 2021
NEW YORK, NY / ACCESSWIRE / July 30, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....
From
The Gross Law Firm
Via
AccessWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Product Safety
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, HMPT and YMM
July 29, 2021
NEW YORK, NY / ACCESSWIRE / July 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
CLASS ACTION UPDATE for OCGN, BLCT and OTLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
July 29, 2021
NEW YORK, NY / ACCESSWIRE / July 29, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
July 29, 2021
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Via
InvestorPlace
Exposures
COVID-19
NASDAQ: OCGN Shareholder Notice: Deadline on August 17, 2021 in Lawsuit Against Ocugen, Inc.
July 27, 2021
San Diego, CA -- (SBWIRE) -- 07/27/2021 -- A Deadline is coming up on August 17, 2021 in the lawsuit for certain investors in Ocugen, Inc. (NASDAQ: OCGN).
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Why Ocugen Stock Rose, Then Slipped Today
July 26, 2021
An analyst launched coverage of the stock with an extremely bullish note, however...
Via
The Motley Fool
Exposures
COVID-19
Ocugen Likely Can’t Get a Boost From the FDA Until 2023
July 22, 2021
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Why Shares of Ocugen Climbed Today
July 19, 2021
The delta variant is lifting the tide of companies associated with COVID testing and prevention.
Via
The Motley Fool
Topics
Death
Exposures
Death
54 Biggest Movers From Yesterday
July 20, 2021
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon...
Via
Benzinga
Ocugen Stock Is Well Past Its Expiration Date and It Shows
July 16, 2021
There won’t be a market for COVAXIN in the US as vaccination rates continue moving up. OCGN stock doesn’t even warrant the price of a dollar.
Via
InvestorPlace
Why Ocugen Shares Are Rallying Today
July 15, 2021
Ocugen, Inc. (NASDAQ: OCGN) shares were advancing strongly Thursday after the biopharma issued a regulatory update. Pennsylvania-based Ocugen said it has initiated a rolling...
Via
Benzinga
OCGN INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit
July 14, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Why Ocugen Stock Skyrocketed 339% in the First Half of 2021
July 14, 2021
The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.
Via
The Motley Fool
Exposures
COVID-19
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering
July 12, 2021
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.
Via
InvestorPlace
Exposures
COVID-19
Why Shares of Ocugen Are Dropping Today
July 09, 2021
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.
Via
The Motley Fool
Exposures
COVID-19
The Outlook for Ocugen Stock Has Deteriorated Further
July 07, 2021
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.
Via
InvestorPlace
Exposures
COVID-19
What's Next For Ocugen Stock As It Nears Key Resistance Level?
July 06, 2021
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported...
Via
Benzinga
Exposures
COVID-19
42 Stocks Moving In Tuesday's Mid-Day Session
July 06, 2021
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...
Via
Benzinga
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory
July 06, 2021
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.
Via
InvestorPlace
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today
July 06, 2021
OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...
Via
Benzinga
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19...
Via
Benzinga
Exposures
COVID-19
28 Stocks Moving in Tuesday's Pre-Market Session
July 06, 2021
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.